Drug Topics March 2020

March 20, 2020

What new gaps will pharmacists need to fill?

March 20, 2020

It’s my hope that 2020 is a profession changing year, starting with the schools of pharmacy.

March 19, 2020

Analysts have forecasted the market for NASH drugs could reach $20 billion by 2025.

March 19, 2020

We asked pharmacists from various settings around the country: “Why did you become a pharmacist, and what keeps you motivated?"

March 18, 2020

From drug information to patient education, these apps can help you be better at everything that you do.

March 18, 2020

When looking to grow business with supplement sales, pharmacists should first educate themselves.

March 18, 2020

Relieving symptoms and optimizing therapies for allergic rhinitis

March 17, 2020

Pharmacy managers and educators offer career advice.

March 17, 2020

On December 23, 2019, the FDA approved ubrogepant for the acute treatment of migraine with and without aura in adult patients.

March 16, 2020

Approximately 1 million individuals are living with multiple sclerosis in the United States, according to the National MS Society.

March 16, 2020

Walk into a pharmacy in 2030 and there’s a good chance you’ll see a pharmacist. And there’s a good chance the pharmacist will have little or nothing to do with dispensing.

March 13, 2020

Creating a place where patients seek diabetes care and counseling.

February 21, 2020

FDA responds to shortages, plus other important updates.

February 18, 2020

Greg Jones, RPh, MBA, director of pharmacy services and his team are doing some amazing things in pharmacy.

February 13, 2020

A UMass Memorial telehealth-based program connects patients with credentialed clinicians who can prescribe medication-assisted treatment for opioid use disorder. 

January 07, 2020

What are some of the factors affecting whether a brand-name drug has generic competition?